All posts by: Paul Wynn

Neovasc’s Reducer System has been included on the NHS High-Cost Tariff Excluded Devices (HCTED) programme, which aims to provide value for money for both hospitals and medical device suppliers. Equipment developed and manufactured by Canadian biotech firm Neovasc for treating Refractory Angina...
Continue Reading →
Today is a very exciting day in our Healthcare 21 journey.  We are delighted to announce that the Healthcare 21 Group has been acquired by AddLife AB Group. AddLife is a Swedish publicly listed Med Tech company. Similar to Healthcare...
Continue Reading →
Taewoong Medical are pleased to announce the opening of their online training centre (OTC). This platform has been designed to offer users across the globe the skills and expertise of using Taewoong products. The free to access platform contains a...
Continue Reading →
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.